If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
CARDIOLOGY
ISSN 2054-3174 Vol 3.1 • February 2015 • emjreviews.com
CONTENTS
EDITORIAL BOARD................................................................................................................................. 4
EDITOR’S PICK: STATE OF THE ART OF AORTIC VALVE IMPLANTATION: INDICATIONS,
OUTCOMES, AND CONTROVERSIES.......................................................................................................... 10
• Pablo Salinas et al.
COST-EFFECTIVENESS OF A NOVEL SELF-APPOSING STENT IN ST-SEGMENT ELEVATION
MYOCARDIAL INFARCTION (STEMI) IN FRANCE................................................................................... 22
• Lieven Annemans et al.
LEFT VENTRICULAR CARDIOMYOPATHY IN MITRAL VALVE PROLAPSE: FACT OR FICTION? 30
• Christina Attenhofer Jost et al.
FUNCTIONAL MITRAL REGURGITATION: I
CARDIOLOGY ISSN 2054-3174
CONTENTS EDITORIAL BOARD.......................
CARDIOLOGY TRANSCATHETER OPTIONS FOR TREATMENT
Editorial Board Editor-in-Chief: Dr Fernando A
Cardiology Prof Robert Page, Professor, Depa
European Medical Journal EMJ Cardiology Vol 3.1
Welcome The field of Cardiology is one which ha
Exceptional speakers will present the three plena
Foreword Dr Fernando Alfonso Hospital
EDITOR’S PICK I wo
or systematic trials were performed, SAVR showed
a careful evaluation of patients, medical treatme
Table 1: Short and mid-term SOU registry UK r
Table 2: Long-term mortality after TAVI. The orig
arterial dissection/rupture and need for covered
practice in most centres is PCI at least on sever
TAVI will also promote advancements in othe
computed tomography predicts moderate or severe p
transcatheter and surgical prosthetic valve
101. Mack MJ et al; STS/ACC TVT Registry. Outcome
SUBSCRIBE FREE TO OUR YOUTUBE CHANNEL www.youtube
COST-EFFECTIVENESS OF A NOVEL SELF-APPOSING ST
would be substantial,4 but recent real-life
not related to MI, and CV death. Therefore, we al
Table 1: Clinical input data for first 30
Table 3: Utility data applied in the model. Event
to conventional DES (€16,291/QALY) but not cost-
Early economic models have some limitations, as i
APPOSITION III investigators. A Post- market
LEFT VENTRICULAR CARDIOMYOPATHY IN MITRAL
(LV) dysfunction and clinical features of HF. An
A 5 10 LV 15 V LA
circulating troponin I concentration correlat
Table 1: Summary of left and right ventricular ab
Myocardial impairment including abnormal LV r
population-based sample of American Indians: t
53. Jaffe AS et al. Mitral valve prolapse: a cons
FUNCTIONAL MITRAL REGURGITATION: IF THE MYOCARDI
prolapse or PM rupture; Type 3: coaptation proxim
Dyssynchrony of the LV results in the dyssynchron
A B Fig
Functional MR OMT CAD therapy Consider CRT Sy
positive response to CRT, it appears unquestionab
versus 2.3%) but a similar perioperative mortalit
indirect annuloplasty. Based on the anatomic
CONCLUSION FMR is a complex disease pr
of mitral repair for functional mitral regur
TRANSCATHETER OPTIONS FOR TREATMENT OF
of application, following established sur
the procedure was documented. Until January
Figure 2: The Carillon Mitral Contour System cons
Treatment of Mitral Regurgitation) have been
Direct annuloplasty Several devices for dir
It has to be emphasised that both patients
programme likely relieved undertreatment
Coll Cardiol. 2009;54:638-51. 26. Lansac E et al.
Would you like to write for the EMJ blog? Intera
CIRCULATING HAEMOGLOBIN LEVELS AND THE RISK OF
Changes in diet and lifestyle promoted by the hos
apolipoproteins A1 and B), anthropometry (body ma
Table 1A continued. Risk factors, dietary intake
= 0.18, P<0.001) and paraoxonase activity (partia
Table 2: Haematological parameters and oxidative
genetic predisposition to bloodborne disorder
However, HDL cholesterol and homocysteine were no
REFERENCES 1. Reddy KS, Yusuf S. Emerging epidem
THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERL
that cholesterol is transported to the arterial w
Table 1: Change in low-density lipoprotein (LDL)
Table 3: Change in cholesterol retention fraction
measured colourimetrically. Once HDL cholesterol
two cholesterol transport fractions in predicting
0.7 0.6 0.5 0.4 Rate of Plaque Progression
thus is superior to LDL cholesterol in predicting
0.25 mmol/l lower than one calculated by the ne
on the progression of coronary athero
EUROPEAN MEDICAL JOURNAL provides influential arti
HOW I TREAT: CORONARY HEART DISEAS THE PLEIOTR
Furthermore, numerous large observational studies
SUBSCRIBE TO RECEIVE THE LATEST CATIONS PUBLI